Biliary atresia (BA) is a life-threatening liver disease of infancy in which early surgery can restore bile flow but rarely ...
UK biotech Engitix has raised a $25 million series A extension from existing investor Netherton Investments, investing on behalf of BlueCrest Capital Management co-founder Mike Platt. The funding will ...
NewcelX Ltd. (Nasdaq: NCEL) ("NewcelX" or the "Company"), a clinical-stage biotechnology company advancing regenerative ...
Royal Biologics, a leader in innovative biologic solutions for wound care and tissue repair, today announced it has signed an ...
This review innovatively proposes the use of electrospinning to fabricate electroactive fibrous scaffolds, which mimic the structure of the extracellular matrix while providing electrical activity, ...
Proteomic mass spectrometry can identify key biomarkers in IPF, aiding in diagnosis and prognosis despite the disease's ...
StimLabs®, a leading regenerative medicine company, announces the launch of Allacor P, the first medical device derived from human umbilical cord extracellular matrix (ECM). Allacor P was awarded an A ...
Extracellular vesicles (EVs), including exosomes, microvesicles, apoptotic bodies, and many other EV subtypes, have emerged ...
The utilization of biodegradable biomaterials as a therapeutic modality for musculoskeletal tissue regeneration has emerged as a promising avenue for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback